vimarsana.com
Home
Live Updates
EpicentRx Announces Oral Presentation for the Most Clinically Advanced TGF-β Ligand Trap, AdAPT-001, at the Upcoming 2024 ASCO Annual Meeting : vimarsana.com
EpicentRx Announces Oral Presentation for the Most Clinically Advanced TGF-β Ligand Trap, AdAPT-001, at the Upcoming 2024 ASCO Annual Meeting
/PRNewswire/ -- EpicentRx, a clinical-stage biopharmaceutical company, announced that The American Society of Clinical Oncology (ASCO) has invited Dr. Anthony...
Related Keywords
United States ,
American ,
Prnewswire Epicentrx ,
Lucyb Kennedy ,
Anthonyp Conley ,
Saar Yaniv ,
Ashley Thomaz ,
Business Development Contact ,
American Society Of Clinical Oncology ,
Md Anderson Cancer Center ,
Epicentrx Inc ,
American Society ,
Clinical Oncology ,
Cancer Center ,
Sarcoma Specialist ,
Oral Abstract Session ,
Developmental Therapeutics ,
Development Contact ,
vimarsana.com © 2020. All Rights Reserved.